Clinical trial
Study to Evaluate the Efficacy and Safety of MEDI9929 (AMG 157) in Adult…
NCT02054130 · MedImmune LLC, Industry · Completed
Key facts
| NCT number | NCT02054130 |
|---|---|
| Title | Study to Evaluate the Efficacy and Safety of MEDI9929 (AMG 157) in Adult Subjects With Inadequately Controlled, Severe Asthma |
| Official title | A Phase 2 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of MEDI9929 in Adult Subjects With Inadequately Controlled, Severe Asthma |
| Lead sponsor | MedImmune LLC, Industry |
| Collaborators | Amgen Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug |
| Interventions | Placebo, MEDI9929 70 mg, MEDI9929 210 mg, MEDI9929 280 mg |
| Enrollment | 584 |
| Start date | Dec 13, 2013 |
| Primary completion | Dec 12, 2016 |
| Completion | Mar 1, 2017 |
| First posted | Feb 4, 2014 |
| Last update posted | Dec 4, 2018 |
| Countries | Bulgaria, Czechia, Hungary, Israel, Japan, Latvia, Lithuania, Serbia, Slovakia, South Africa, Ukraine, United States |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: